Rankings
▼
Calendar
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$240M
-5.9% YoY
Gross Profit
$91M
37.8% margin
Operating Income
-$895,000
-0.4% margin
Net Income
$5M
1.9% margin
EPS (Diluted)
$0.09
Cash Flow
Operating Cash Flow
$39M
Free Cash Flow
$4M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$455M
Total Liabilities
$117M
Stockholders' Equity
$337M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$240M
$255M
-5.9%
Gross Profit
$91M
$104M
-12.9%
Operating Income
-$895,000
$16M
-105.7%
Net Income
$5M
$11M
-57.2%
← Q4 2016
All Quarters
Q1 2017 →
AMPH FY 2017 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena